Xiangyu Medical Co. Ltd. A (688626) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Based on the latest financial reports, Xiangyu Medical Co. Ltd. A (688626) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥18.05 Million ≈ $2.64 Million USD) by net assets (CN¥2.04 Billion ≈ $298.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 688626 stock market capitalisation for the company's overall valuation and market capitalisation.

Xiangyu Medical Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Xiangyu Medical Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Xiangyu Medical Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Xiangyu Medical Co. Ltd. A ranked by their cash flow conversion efficiency. Explore 688626 cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Trupanion Inc NASDAQ:TRUP	0.051x
Sansteel MinGuang Co Ltd Fujian SHE:002110	0.114x
Sinar Mas Agro Resources and Technology Tbk PT JK:SMAR	0.103x
Alkyl Amines Chemicals Limited NSE:ALKYLAMINE	0.049x
Corporación Interamericana de Entretenimiento S.A.B. de C.V MX:CIEB	-0.085x
Procept Biorobotics Corp NASDAQ:PRCT	-0.017x
Guangxi Wuzhou Zhongheng Group Co Ltd SHG:600252	-0.012x
Rackspace Technology Inc NASDAQ:RXT	-0.004x

Annual Cash Flow Conversion Efficiency for Xiangyu Medical Co. Ltd. A (2017–2024)

The table below shows the annual cash flow conversion efficiency of Xiangyu Medical Co. Ltd. A from 2017 to 2024. View latest Xiangyu Medical Co. Ltd. A stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.05 Billion ≈ $300.68 Million	CN¥178.59 Million ≈ $26.13 Million	0.087x	-19.63%
2023-12-31	CN¥2.11 Billion ≈ $308.38 Million	CN¥227.91 Million ≈ $33.35 Million	0.108x	+12.36%
2022-12-31	CN¥1.94 Billion ≈ $283.86 Million	CN¥186.70 Million ≈ $27.32 Million	0.096x	+12.88%
2021-12-31	CN¥1.95 Billion ≈ $284.70 Million	CN¥165.88 Million ≈ $24.27 Million	0.085x	-70.72%
2020-12-31	CN¥743.29 Million ≈ $108.77 Million	CN¥216.40 Million ≈ $31.67 Million	0.291x	+2.18%
2019-12-31	CN¥547.28 Million ≈ $80.08 Million	CN¥155.94 Million ≈ $22.82 Million	0.285x	+59.30%
2018-12-31	CN¥414.81 Million ≈ $60.70 Million	CN¥74.20 Million ≈ $10.86 Million	0.179x	-70.12%
2017-12-31	CN¥99.09 Million ≈ $14.50 Million	CN¥59.31 Million ≈ $8.68 Million	0.599x	--

About Xiangyu Medical Co. Ltd. A

SHG:688626 China Medical Devices

Market Cap

$1.03 Billion

CN¥7.04 Billion CNY

Market Cap Rank

#8848 Global

#2162 in China

Share Price

CN¥44.00

Change (1 day)

+6.59%

52-Week Range

CN¥36.97 - CN¥87.12

All Time High

CN¥116.87